IBL HealthCare Statistics

Total Valuation

IBL HealthCare has a market cap or net worth of PKR 3.18 billion. The enterprise value is 3.50 billion.

Market Cap	3.18B
Enterprise Value	3.50B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

IBL HealthCare has 85.67 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	85.67M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	1.16%
Owned by Institutions (%)	4.42%
Float	21.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
PB Ratio	1.44
P/TBV Ratio	1.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.28, with an EV/FCF ratio of -54.78.

EV / Earnings	-149.16
EV / Sales	0.94
EV / EBITDA	22.28
EV / EBIT	23.09
EV / FCF	-54.78

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.18.

Current Ratio	2.25
Quick Ratio	1.34
Debt / Equity	0.18
Debt / EBITDA	2.49
Debt / FCF	-6.12
Interest Coverage	2.52

Financial Efficiency

Return on equity (ROE) is -1.05% and return on invested capital (ROIC) is 3.68%.

Return on Equity (ROE)	-1.05%
Return on Assets (ROA)	2.65%
Return on Invested Capital (ROIC)	3.68%
Return on Capital Employed (ROCE)	6.84%
Revenue Per Employee	12.74M
Profits Per Employee	-80,301
Employee Count	292
Asset Turnover	1.04
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.87% in the last 52 weeks. The beta is 0.97, so IBL HealthCare's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+19.87%
50-Day Moving Average	39.07
200-Day Moving Average	35.37
Relative Strength Index (RSI)	45.25
Average Volume (20 Days)	99,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IBL HealthCare had revenue of PKR 3.72 billion and -23.45 million in losses. Loss per share was -0.27.

Revenue	3.72B
Gross Profit	936.46M
Operating Income	151.45M
Pretax Income	85.29M
Net Income	-23.45M
EBITDA	153.65M
EBIT	151.45M
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 74.22 million in cash and 390.68 million in debt, giving a net cash position of -316.47 million or -3.69 per share.

Cash & Cash Equivalents	74.22M
Total Debt	390.68M
Net Cash	-316.47M
Net Cash Per Share	-3.69
Equity (Book Value)	2.21B
Book Value Per Share	25.85
Working Capital	1.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.60 million and capital expenditures -1.25 million, giving a free cash flow of -63.85 million.

Operating Cash Flow	-62.60M
Capital Expenditures	-1.25M
Free Cash Flow	-63.85M
FCF Per Share	-0.75

Full Cash Flow Statement

Margins

Gross margin is 25.16%, with operating and profit margins of 4.07% and -0.63%.

Gross Margin	25.16%
Operating Margin	4.07%
Pretax Margin	2.29%
Profit Margin	-0.63%
EBITDA Margin	4.13%
EBIT Margin	4.07%
FCF Margin	n/a

Dividends & Yields

IBL HealthCare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.74%
FCF Yield	-2.01%

Dividend Details

Stock Splits

The last stock split was on October 19, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 19, 2023
Split Type	Forward
Split Ratio	1.2

Scores

IBL HealthCare has an Altman Z-Score of 3.58.

Altman Z-Score	3.58
Piotroski F-Score	n/a